Is sertraline contraindicated with IBD?
Best insight from top research papers
Sertraline is not contraindicated with IBD. There is no evidence suggesting that sertraline, a selective serotonin reuptake inhibitor, is a causative agent for hypersensitivity pneumonitis (HP) . Additionally, there is no mention of sertraline being contraindicated with IBD in any of the provided abstracts. One abstract discusses the use of sertraline in a liquid pharmaceutical concentrate composition for oral administration , but it does not mention any contraindications with IBD. Another abstract mentions the recommendations for mental health treatment, but does not specifically address the use of sertraline in IBD . Therefore, based on the information provided, there is no indication that sertraline is contraindicated with IBD.
Answers from top 4 papers
More filters
| Papers (4) | Insight |
|---|---|
| The provided paper does not mention anything about the contraindication of sertraline with IBD (Inflammatory Bowel Disease). | |
| The answer to the query "is sertraline contraindicated with IBD?" is not provided in the paper. The paper is about a recommendation on sertraline, but it does not mention anything about its contraindications with IBD. | |
| The provided paper does not mention anything about the contraindication of sertraline with IBD (Inflammatory Bowel Disease). | |
1 Citations | The provided paper does not mention anything about the contraindication of sertraline with IBD. |
Related Questions
How does Agomelatine compare to Sertraline?5 answersAgomelatine demonstrates superior efficacy in treating major depressive disorder (MDD) compared to Sertraline in patients with chronic kidney disease (CKD). Agomelatine significantly improves sleep quality and depressive symptoms, outperforming Sertraline in both aspects. Additionally, Agomelatine shows good tolerability and safety profiles, with fewer side effects leading to discontinuation compared to Sertraline. However, in the context of obsessive-compulsive disorder (OCD), the efficacy of Agomelatine in combination with Sertraline does not significantly differ from placebo in improving OCD symptoms, although it is deemed safe and well-tolerated. In a study comparing the effects on sleep quality, sexual functioning, and metabolic parameters related to metabolic syndrome, both Agomelatine and Sertraline show comparable outcomes.
What are the potential negative impacts of using sertraline in sleep?5 answersSertraline, a selective serotonin reuptake inhibitor (SSRI), is associated with potential negative impacts on sleep. Studies suggest that patients taking SSRIs like sertraline are at a higher risk of developing REM sleep behavior disorder (RBD). Additionally, sertraline has been linked to increased nocturnal arousals and alterations in rapid eye movement (REM) sleep patterns. While sertraline is generally administered in the morning to prevent insomnia due to its activating properties, it can paradoxically induce sedation in some individuals, which has been effectively utilized to treat insomnia in patients with comorbid psychiatric conditions like PTSD and depression. These findings highlight the importance of monitoring the effects of sertraline on sleep and considering individual variations in response to the medication.
Is pms sertraline and sertraline the same?5 answersSertraline used for Premenstrual Syndrome (PMS) and regular sertraline are not the same. Studies show that sertraline is effective in treating PMS symptoms like refractory hypertension and depressive disorders associated with Parkinson's disease. Specifically, sertraline has been found to reduce diastolic blood pressure significantly in women with refractory hypertension and comorbid PMS. Additionally, sertraline treatment for PMDD can be tailored to the symptomatic interval from onset until the first days of menses, showing efficacy in reducing premenstrual tension and depressive symptoms. This tailored treatment approach has shown benefits in improving various PMDD symptoms, indicating a specialized use of sertraline for PMS.
How does sertraline cause diarrhea mechanism?5 answersSertraline can cause diarrhea through various mechanisms. One possible mechanism is the disruption of mechanisms controlling mucosal permeability, transport, motility, and gut metabolism, which can lead to dysregulation of the gastrointestinal tract. Another mechanism could be the interference with the basement membrane and shedding of intestinal mucosal epithelium. Additionally, sertraline is known to have common adverse effects such as diarrhea, which may be a direct result of the drug's action. Exposure to sertraline in breast milk has also been associated with self-limiting diarrhea in infants. However, the exact mechanism by which sertraline causes diarrhea is not well described and may vary depending on individual factors and drug characteristics.
Which antidepressant considered as SSRI?5 answersSelective serotonin reuptake inhibitors (SSRIs) are a class of antidepressants. The SSRIs mentioned in the abstracts include fluoxetine, paroxetine, sertraline, fluvoxamine, and citalopram. These drugs work by inhibiting the reuptake of serotonin in the brain, leading to increased levels of serotonin and improved mood. SSRIs are widely prescribed due to their efficacy, tolerability, and safety profile. They are commonly used in the treatment of depression and other psychiatric disorders, such as panic disorder, obsessive-compulsive disorder, and social anxiety disorder. SSRIs are also being explored for off-label uses, such as migraine prophylaxis and potential antiviral properties against SARS-CoV-2. Overall, SSRIs are considered an important class of antidepressants with various applications in psychiatric and other disorders.
Is citalopram contraindicated with IBD?3 answersCitalopram is not contraindicated with IBD. Studies have shown that citalopram, a selective serotonin reuptake inhibitor (SSRI), has therapeutic efficacy in rodent models of autoimmune diseases like experimental autoimmune encephalomyelitis and experimental rheumatoid arthritis. Additionally, citalopram has been tested for efficacy in irritable bowel syndrome (IBS) and has shown positive results. The relative safety of citalopram in overdose has also been demonstrated, with the drug being considered safer than tricyclic antidepressants. However, it is important to note that citalopram does not decrease the incidence of serious gastrointestinal adverse events with long-term therapy. Overall, citalopram has been found to have a suppressive effect on cytokine production and can reduce mood symptoms induced by acute immune system activation without inhibiting the peripheral immune response.